Export 5 results:
Auteur Title [ Type(Desc)] Année
Filtres: Auteur is de la Fuente-Sandoval, Camilo  [Enlever les filtres]
Journal Article
Winterburn JL, Voineskos AN, Devenyi GA, Plitman E, de la Fuente-Sandoval C, Bhagwat N, Graff-Guerrero A, Knight J, Chakravarty MM.  2017.  Can we accurately classify schizophrenia patients from healthy controls using magnetic resonance imaging and machine learning? A multi-method and multi-dataset study. Schizophr Res.
Hui SCN, Mikkelsen M, Zöllner HJ, Ahluwalia V, Alcauter S, Baltusis L, Barany DA, Barlow LR, Becker R, Berman JI et al..  2021.  Frequency drift in MR spectroscopy at 3T.. Neuroimage. 241:118430.
Plitman E, Nakajima S, de la Fuente-Sandoval C, Gerretsen P, Chakravarty MM, Kobylianskii J, Chung JKu, Caravaggio F, Iwata Y, Remington G et al..  2014.  Glutamate-mediated excitotoxicity in schizophrenia: a review.. Eur Neuropsychopharmacol. 24(10):1591-605.
Plitman E, Patel R, Chung JKu, Pipitone J, Chavez S, Reyes-Madrigal F, Gómez-Cruz G, León-Ortiz P, Chakravarty MM, de la Fuente-Sandoval C et al..  2016.  Glutamatergic Metabolites, Volume and Cortical Thickness in Antipsychotic-Naive Patients with First-Episode Psychosis: Implications for Excitotoxicity.. Neuropsychopharmacology. 41(10):2606-13.
Reyes-Madrigal F, Guma E, León-Ortiz P, Gómez-Cruz G, Mora-Durán R, Graff-Guerrero A, Kegeles LS, Chakravarty MM, de la Fuente-Sandoval C.  2022.  Striatal glutamate, subcortical structure and clinical response to first-line treatment in first-episode psychosis patients.. Prog Neuropsychopharmacol Biol Psychiatry. 113:110473.